However, because we did not assess the expression levels of KLF4 or the probability of survival in TNBC cells, we next analyzed the role of KLF4 and NOXA in overall breast cancers without classification of hormone receptor expression levels or the p53 mutation status. This evidence concerns the gene NR4A1 and breast carcinoma.